# NIH Reporter #11406764

Preclinical development of a novel therapeutic for Parkinson's disease

**Recipient:** SINOPIA BIOSCIENCES, INC.

**Award Amount:** $3,000,000.00
**Ceiling:** $3,000,000.00

**Awarded:** September 07, 2026

**Identifier:** 11406764

Award for preclinical drug development targeting Parkinson's Disease, including toxicology studies and IND preparation, funded by NINDS.

### Description

The project involves preclinical drug development for Parkinson's Disease, aiming to complete toxicology studies and prepare for IND submission. Funded by the National Institute of Neurological Disorders and Stroke.

[View original record](https://reporter.nih.gov/search/0C83gI3MXki4-tEhFD4UKQ/project-details/11406764)